All In MedTech

510(k) device

Ekso (version 1.1) and Ekso GT (version 1.2)

Last checked: Nov 19, 2026Source: FDA, CMS, ClinicalTrials.gov, PubMed

FDA decisions

2

510(k) pathway

Device trials

45

Naming "Ekso"

MAUDE reports

5

Brand "Ekso", since 2015

PubMed studies

63

Mentioning "Ekso"

AI summary across all sources

Written by AI from the FDA, CMS, ClinicalTrials.gov, MAUDE and PubMed data on this page, plus web searches for payment facts.

Product review deck

A slide deck reviewing Ekso (version 1.1) and Ekso GT (version 1.2)

About ten slides on the technology, clinical evidence, regulatory history and commercialization, built with AI from the data on this page and web research, with sources. Download it as PowerPoint to edit or as PDF to share.

  • Executive summary and key facts
  • Technology
  • Clinical evidence and trials
  • Regulatory history and safety
  • Reimbursement, market and competition
  • Risks, outlook and sources

AI-written from public data and may contain mistakes. Check each fact against its source before relying on it. Not investment, legal, reimbursement or medical advice.

FDA decisions

The newest 2 of 2 decisions filed under this name.

Medicare coverage

National and local coverage documents whose titles match this device or its device type. Payment add-ons (NTAP, pass-through, TCET) and likely codes are covered in the summary above.

How devices get paid for

No Medicare coverage document has a title matching this device or device type. Many devices are paid under existing codes without one.

Clinical trials

Device studies on ClinicalTrials.gov that name "Ekso", any status and sponsor, newest update first.

Open in Trial Radar

42 more trials with a free account

Adverse event reports (MAUDE)

Reports received since 2015 naming the brand "Ekso", and for the whole product code for context.

This brand

5 reports: 3 malfunction, 2 injury, 0 death

Whole product code PHL

57 reports: 7 malfunction, 50 injury, 0 death

Newest reports for this brand

  • EKSO BIONICS

    MW5112195 · Received Sep 21, 2022 · Event dated Aug 22, 2022

    Device type: Powered Exoskeleton (PHL)

    Device problem as coded: Unexpected Therapeutic Results

    Patient problem as coded: Bone Fracture(s); Sleep Dysfunction; Cramp(s) /Muscle Spasm(s); Swelling/ Edema

  • EKSOInjury

    EKSO BIONICS

    3009495988-2018-00001 · Received Oct 2, 2018 · Event dated May 15, 2018

    Device type: Powered Exoskeleton (PHL)

    Device problem as coded: Adverse Event Without Identified Device or Use Problem

    Patient problem as coded: Bone Fracture(s); Joint Swelling

  • EKSOMalfunction

    EKSO BIONICS, INC.

    7572849 · Received Jun 6, 2018 · Event dated May 15, 2018

    Device type: Powered Exoskeleton (PHL)

    Device problem as coded: Appropriate Device Problem Term/Code Not Available

    Patient problem as coded: Edema; Swelling; Spinal Cord Injury

2 more reports with a free account

All reports in MAUDE Monitor

Recalls

From FDA's recall database. FDA lists each recalled product separately, so one recall can appear several times. A recall is often a correction or a labeling change, not a removal from the market.

No recall in FDA's data is linked to these FDA numbers.

Published research

The most relevant PubMed records for "Ekso"[tiab]. The summary above synthesizes these.

PubMedGoogle ScholarLiterature search

Other devices of this type

Also filed under product code PHL.

For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.